Improved Pharma Showcases Innovative Research at AAPS 2026 PHARMSCI 360 Exhibition

Improved Pharma Showcases Innovative Research at AAPS 2026 PHARMSCI 360

Improved Pharma has taken a significant step forward at the AAPS 2026 PHARMSCI 360 exhibition, which is being held in West Lafayette, Indiana. Occupying an expansive corner booth (#1518) shared with Varda Space Industries (#1520), the company is positioned prominently on the main aisle next to Stage 1 of the event. The representatives for Improved Pharma, Stephen Byrn, Pam Smith, Susan Bogdanowich-Knipp, and Ruba Alajlouni, are readily available to discuss research and development needs, current studies in solid-state chemistry, formulation design, and the intriguing field of crystallization in microgravity.

One centerpiece of Improved Pharma's exhibition is the significant work on solid lipid nanoparticle formulations, showcased through poster W1030-04-20 presented by Ruba Alajlouni in collaboration with Purdue University. Their research focuses on the "Identification of an Unknown Impurity in an Etoposide Phosphate Solid Lipid Nanoparticle Formulation by LC-HRAMS(/MS)." This work unveils a method for identifying previously unknown impurities in pharmaceutical formulations. It details the formulation process changes that were implemented to prevent the formation of such impurities, marking a pivotal achievement in the quest for purer pharmaceutical products.

Additionally, Improved Pharma is excited to present a joint research effort with BASF, showcased in poster W1130-09-52 titled "Effect of Secondary Vacuum Drying on Dissolution Performance and Limit of Congruency in Spray-Dried Danazol-Copovidone ASDs." This research highlights how a secondary vacuum drying process impacts the limit of congruency, defining practical formulation boundaries for maximizing drug loading. Furthermore, it informs on how this technique can influence residual solvent content, amorphous stability, and dissolution behavior, vital aspects in drug formulation and delivery.

Founded in 2006 by industry stalwarts Stephen and Sarah Byrn, Improved Pharma is committed to advancing pharmaceutical methodologies, formulations, and processes. The organization operates with a focus on solid-state form studies, formulation design, and more, offering analytical testing and expert consulting services that help in the development and defense of intellectual property issues within the pharmaceutical sector. The team's wealth of experience ensures they remain at the forefront of pharmaceutical innovation.

As the AAPS 2026 PHARMSCI 360 exhibition continues, attendees are encouraged to stop by booth #1518 to engage with Improved Pharma's team. Whether discussing pressing R&D needs or engaging in insightful conversations about the latest in formulation techniques, this is an opportunity to get up close and personal with the future of pharmaceutical science. The knowledge and expertise presented by Improved Pharma reflects their unwavering commitment to advancing the pharmaceutical industry, making them a key player at this year's event.

Don't miss out on the chance to learn from the leaders in the field and see firsthand how Improved Pharma is paving the way for pharmaceutical advancements and innovations.